Vulvar Dystrophy and Other Premalignant Lesions of the Vulva — The View of the Gynecologist

  • H. F. Nauth
Conference paper


Two entirely different vulvar entities seem to contribute to carcinogenesis, i.e., intraepithelial HPV infection, on the one hand, and stromal, chiefly subepithelial, dystrophy, mainly occurring in the form of hyperplasia, on the other. Their frequency rate is high and steadily rising [2, 10, 23].


Premalignant Lesion Vulvar Cancer Lichen Sclerosus Cervical Cytology Condyloma Acuminata 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Friedrich EG (1976) Vulvar disease. In: Friedmann EA (ed) Major problems in obstetrics and gynecology, 9th edn. Saunders, PhiladelphiaGoogle Scholar
  2. 2.
    Gissmann L (1984) Papilloma viruses and their association with cancer in animals and in man Cancer Sury 3: 161Google Scholar
  3. 3.
    Golstein Ai, Kent DR (1975) All vulvar lesions should be biopsied. Am J Obstet Gyneco 1121: 173Google Scholar
  4. 4.
    Hagedorn M (1987) Lichen sclerosus et atrophicus: Behandlung mit ThymUvocal-Creme. Aktuell Dermatol 13: 30–33Google Scholar
  5. 5.
    Hoffman P (1970) Histologie und Prognose des Vulvarkarzinoms. Geburtshilfe Frauenheilkd 30: 452Google Scholar
  6. 6.
    Hughes RR (1971) Early diagnosis and management of premalignant lesions and early invasive cancers of vulva. South Med J 64: 1490PubMedCrossRefGoogle Scholar
  7. 7.
    Janovski NA, Douglas CP (1972) Diseases of the vulva. Harper and Row, HagerstrownGoogle Scholar
  8. 8.
    Kaufman RH, Woodruff JD (1976) Historical background in developmental stages of the new nomenclature. J Reprod Med 17: 133Google Scholar
  9. 9.
    Korting GW (1981) Spezielle Dermatologie, Chaps 44–49. Thieme, Stuttgart (Dermatologie in Praiis und Klinik, vol 4 )Google Scholar
  10. 10.
    Meisels A, Morin C (1981) Human papilloma virus and cancer of uterine cervix. Gynecol Oncol 12: 111CrossRefGoogle Scholar
  11. 11.
    Nauth HF (1982) Vulva-Diagnostik. Fortschr Med 10: 396Google Scholar
  12. 12.
    Nauth HF (1982) Vulva-Diagnostik. Fortschr Med 11: 478Google Scholar
  13. 13.
    Nauth HF (1982) Zur lokalen Testosterontherapie des Lichen sclerosus. Geburtshilfe Frauenheilkd 42: 476–481PubMedCrossRefGoogle Scholar
  14. 14.
    Nauth HF (1986) Vulvazytologie. Thieme, StuttgartGoogle Scholar
  15. 15.
    Nauth HF, Haas M (1985) Cytologic and histologic observations on the sex hormone dependence of the vulva. J Reprod Med 30: 667–674PubMedGoogle Scholar
  16. 16.
    Nauth HF, Schilke E (1982) Cytology of the exfoliative layer in normal and diseased vulvar skin: correlation with histology. Acta Cytol 26: 269PubMedGoogle Scholar
  17. 17.
    Nauth HF, Neumann GK, Feilen KD (1987) Structural and morphometric analysis of para-and dyskeratotic cells exfoliated in various vulvar lesions: correlation with data of cervical cytology. Anal Quant Cytol 9: 243–252Google Scholar
  18. 18.
    Papanicolaou GH, Traut HF (1947) Diagnosis of uterine cancer by vaginal smear. Commonwealth Fund, New YorkGoogle Scholar
  19. 19.
    Pereira L, Klassen T, Barringer JR (1980) Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immunol 29: 724Google Scholar
  20. 20.
    Romppanen U et al. (1986) Orale Behandlung der Dystrophie der Vulva mit einem aromatischen Retinoid, Etretinat. Geburtshilfe Frauenheilkd 46: 242–247PubMedCrossRefGoogle Scholar
  21. 21.
    Schneider A et al. (1987) Interferon treatment of human genital papillomavirus infection: importance of viral type. Int J Cancer 40: 610–614PubMedCrossRefGoogle Scholar
  22. 22.
    Seidl S (1974) Praktische Karzinomfrühdiagnostik in der Gynäkologie. Thieme, StuttgartGoogle Scholar
  23. 23.
    Sexually Transmitted Diseases (1980) Extract from the Annual Report of the Chief Medical Office of the Department of Health and Social Security for the Year 1978. Br J Vener Dis 56: 178Google Scholar
  24. 24.
    Volk M, Schmidt-Matthiesen H (1983) Therapieergebnisse beim Vulvakarzinom. Arbeitsgem Gynaekol Onkol 4: 13Google Scholar
  25. 25.
    Wilkinson EJ (1989) New nomenclature in vulvar disease. The Calposcopist 21: 1–3Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • H. F. Nauth

There are no affiliations available

Personalised recommendations